Course and outcome of Early Lyme borreliosis in patients with hematological malignancies

Vera Maraspin; Eva Ružić-Sabljić; Lara Lusa; Franc Strle

doi:10.1093/cid/civ341

Course and outcome of Early Lyme borreliosis in patients with hematological malignancies

Clin Infect Dis. 2015 Aug 1;61(3):427-31. doi: 10.1093/cid/civ341. Epub 2015 May 8.

Authors

Vera Maraspin¹, Eva Ružić-Sabljić², Lara Lusa³, Franc Strle¹

Affiliations

¹ Department of Infectious Diseases, University Medical Center Ljubljana.
² Institute of Microbiology and Immunology.
³ Institute for Biostatistics and Medical Informatics, Medical Faculty, University of Ljubljana, Slovenia.

PMID: 25956890
DOI: 10.1093/cid/civ341

Abstract

Patients with erythema migrans and underlying hematological malignancy more often had signs of disseminated Lyme borreliosis and more frequently needed antibiotic retreatment than sex-, age-, and antibiotic treatment-matched immunocompetent persons with erythema migrans. However, the outcome was excellent in both groups.

Keywords: Lyme borreliosis; erythema migrans; hematological malignancies; lymphoid neoplasms; outcome.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Aged
Anti-Bacterial Agents / therapeutic use
Case-Control Studies
Erythema Chronicum Migrans
Female
Hematologic Neoplasms / complications*
Humans
Lyme Disease / complications*
Lyme Disease / drug therapy*
Male
Middle Aged
Treatment Outcome
Young Adult

Substances

Anti-Bacterial Agents